Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
HemoClear BV logo — Platelet-rich red blood cells for autologous blood transfusi...

HemoClear BV

Platelet-rich red blood cells for autologous blood transfusion

Founded 2015 The Netherlands The Netherlands 5 employees Manufacturing, Medical Devices

General Information

Company Name HemoClear BV
Founded Year 2015
Location The Netherlands The Netherlands +1
Employees 5
Industries Manufacturing, Medical Devices
Social

Get notified when HemoClear BV moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About HemoClear BV

HemoClear BV is a manufacturing and medical devices company founded in 2015 with the aim to provide platelet-rich red blood cells for autologous blood transfusion. The innovative design of the HemoClear blood filter allows for the recovery of red blood cells from patients' shed blood during severe blood loss. Utilizing cross-flow filtration by gravity, the sterile HemoClear device demonstrates a high degree of specificity for erythrocytes, separating them from other fluids and plasma. The filtered erythrocytes then undergo re-infusion, while the plasma fluid containing toxins and pathological elements is destructed as waste. Autologous blood transfusion, derived from the same individual, is gaining widespread acceptance as the preferred choice whenever possible. This method presents various advantages such as reduced risk of transmission of infection, transfusion reactions, and immunosuppression. It also eliminates the need for extensive compatibility testing and reduces the demand on allogeneic blood supplies. Furthermore, it may be acceptable to some Jehovah's Witness patients. HemoClear BV's technology and focus on improving the efficiency and safety of blood transfusions present significant potential in the medical field. However, it's essential for the company to attract substantial investment to scale their operations and enhance market penetration. With the right investors and tailored strategic partnerships, HemoClear BV could revolutionize the landscape of blood transfusion technology and make a substantial impact in the medical industry.

Taxonomy: Autologous blood transfusion, Blood filter, Blood management, Patient blood management, Cell salvage, Platelet rich, Red blood cells, Perfusionist, Cardio anesthesiologist, Cardiac anesthesiologist, Obstetrics, Intensivist, Blood bank, Medical technology, Healthcare innovation

No funding data available for HemoClear BV yet.

Get notified when HemoClear BV raises funding

HemoClear BV Alternatives & Competitors

HemoClear BV vs
Macopharma
Macopharma France

Blood is Life, we support Life.

872 employees
Biotechnology, Health Care
HemoClear BV vs
Geron Corporation
Geron Corporation

Changing lives by changing the course of blood cancer.

Post Ipo Equity
356 employees
Biopharma, Biotechnology
HemoClear BV vs
Community Blood Center of Greater Kansas City
Community Blood Center of Greater Kansas City United States

Save a Life. Right Here. Right Now.

194 employees
Health Care

FAQ About HemoClear BV

Platelet-rich red blood cells for autologous blood transfusion
HemoClear BV was founded in 2015.
HemoClear BV is headquartered in The Netherlands.
HemoClear BV operates in the following industries: Manufacturing, Medical Devices.
HemoClear BV has approximately 5 employees.
Top alternatives and competitors to HemoClear BV include Macopharma, Geron Corporation, Community Blood Center of Greater Kansas City, LifeSouth Community Blood Centers, ImmunoTek Bio Centers, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HemoClear BV and Macopharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors HemoClear BV and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy